Niocorp Developments Ltd (NB)

[tedro84]

Most of the changes are to section 19 and provide more information about the potential scandium market and how Matheson arrived at his projections. This section was pretty thin to begin with. I would not look much further into it other than a request for further detail.

The added risk factors to section 25 could be reason for concern. One of them is something that many of us have also questioned. SRK says that “Niocorp may not receive specialty chemical pricing for its scandium.”

Now if you regularly peruse 10k’s you know that most companies try to disclose any remotely possible risk, so there may not be much to this, but it would look a lot better if it was included from the beginning.